Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®

• Type: Article in International Scientific Journal
• Date: 2024

Authors

Bousquet, J (Author) Other; Sousa Pinto, B (Author) FMUP; Anto, JM (Author) Other; Bedbrook, A (Author) Other; Czarlewski, W (Author) Other; Ansotegui, IJ (Author) Other; Bergmann, KC (Author) Other; Braido, F (Author) Other; Brussino, L (Author) Other; Cecchi, L (Author) Other; Loureiro, CC (Author) Other; Cruz, AA (Author) Other; Devillier, P (Author) Other; Fiocchi, A (Author) Other; Gemicioglu, B (Author) Other; Haahtela, T (Author) Other; Ivancevich, JC (Author) Other; Klimek, L (Author) Other; Kulus, M (Author) Other; Kuna, P (Author) Other; Kupczyk, M (Author) Other; Kvedariene, V (Author) Other; Larenas Linnemann, DE (Author) Other; Louis, G (Author) Other; Louis, R (Author) Other; Makris, M (Author) Other; Morais Almeida, M (Author) Other; Niedoszytko, M (Author) Other; Ohta, K (Author) Other; Ollert, M (Author) Other; Papadopoulos, N (Author) Other; Patella, V (Author) Other; Pétré, B (Author) Other; Pfaar, O (Author) Other; Puggioni, F (Author) Other; Quirce, S (Author) Other; Regateiro, FS (Author) Other; Roche, N (Author) Other; Rouadi, PW (Author) Other; Samolinski, B (Author) Other; Sastre, J (Author) Other; Schleich, F (Author) Other; Scichilone, N (Author) Other; Taborda Barata, L (Author) Other; Toppila Salmi, S (Author) Other; Valiulis, A (Author) Other; Koyuncu, IV (Author) Other; Ventura, MT (Author) Other; Yorgancioglu, A (Author) Other; Fonseca, J (Author) FMUP; Zuberbier, T (Author) Other

Journal

Title: Clinical and Translational Allergy

Vol. 14

Publisher: Wiley-Blackwell

Indexing

ISI Web of Knowledge - 0 Citations

Scopus - 0 Citations

Other information

Authenticus ID: P-017-2AA

DOI: 10.1002/clt2.12390

Abstract (EN): Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air (R) (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air (R) in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 17